Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00501-8
PubMed Identifier: 33640038
Publication URI: http://europepmc.org/abstract/MED/33640038
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10279
ISSN: 0140-6736